Sonoma Pharmaceuticals Inc
NASDAQ:SNOA

Watchlist Manager
Sonoma Pharmaceuticals Inc Logo
Sonoma Pharmaceuticals Inc
NASDAQ:SNOA
Watchlist
Price: 3.64 USD 1.68%
Market Cap: 6.2m USD

Wall Street
Price Targets

SNOA Price Targets Summary
Sonoma Pharmaceuticals Inc

Wall Street analysts forecast SNOA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for SNOA is 15.1 USD with a low forecast of 14.95 USD and a high forecast of 15.54 USD.

Lowest
Price Target
14.95 USD
311% Upside
Average
Price Target
15.1 USD
315% Upside
Highest
Price Target
15.54 USD
327% Upside
Sonoma Pharmaceuticals Inc Competitors:
Price Targets
002262
Jiangsu Nhwa Pharmaceutical Co Ltd
25% Upside
000520
Samil Pharmaceutical Co Ltd
37% Upside
4507
Shionogi & Co Ltd
4% Downside
4887
Sawai Group Holdings Co Ltd
9% Upside
MARI
Marinomed Biotech AG
177% Upside
6996
Antengene Corporation Ltd
85% Upside
VIRP
Virbac SA
16% Upside

Revenue
Forecast

Revenue Estimate
Sonoma Pharmaceuticals Inc

For the last 13 years the compound annual growth rate for Sonoma Pharmaceuticals Inc's revenue is 1%. The projected CAGR for the next 3 years is 24%.

1%
Past Growth
24%
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Sonoma Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Miss

Net Income
Forecast

Net Income Estimate
Sonoma Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-98%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is SNOA's stock price target?
Price Target
15.1 USD

According to Wall Street analysts, the average 1-year price target for SNOA is 15.1 USD with a low forecast of 14.95 USD and a high forecast of 15.54 USD.

What is Sonoma Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
24%

For the last 13 years the compound annual growth rate for Sonoma Pharmaceuticals Inc's revenue is 1%. The projected CAGR for the next 3 years is 24%.

Back to Top